Member Login

Effervescence. Biotech and Healthcare Digital Partnering [partner event]

  • 15 Mar 2021
  • 9:00 AM
  • 17 Mar 2021
  • 3:00 PM
  • Virtual event
  • 51

Registration


Registration is closed


Dates: March 15-17, 2021 at 9 am EST 

Participants: investors, entrepreneurs, scientists, start-ups, established companies

Subsectors: pharmaceuticals, biopharmaceuticals, oncology, infectious diseases, imaging and medical devices, life science, health technology

Countries covered: Canada, the USA, Eurasia

  • Canadian biotech and healthcare industry

The world’s second-highest number of bio-tech companies are concentrated in Canada (after USA). Canada represents the 10th largest market for pharmaceutical sales.  It is Canada’s infrastructure, talent and ready access to key markets that helps draw the world’s largest life sciences companies in Canada including Pfizer, AstraZeneca, Gilead, Novartis, Johnson-Johnson and others conducting research, running clinical trials and manufacturing new drugs. 

With hot spots for cancer research, radiation therapies, regenerative treatments, brain and vascular health from coast to coast, multinational organizations recognize that life-changing advancements in patient care are happening in Canada. Innovative lifesaving treatment protocols, pharmaceutical drug therapies and medical devices developed in Canada contribute to the place of this country as a world leader in health sciences. Canada’s leadership in digital technology and robotics is helping to change patient care through future-focused advancements in everything from medtech to medical manufacturing.

  • Eurasian healthcare industry

Countries doing well in the biotech and healthcare industries are those with strong incentives for technology development and a range of options for obtaining research funding and the biotechnological sector of Eurasian countries is doing just that. The Governments are nurturing the sector rapidly. Numerous government programs attract talents, foreign technologies and investment as well as launch brand new centres of excellence. 


The 3-day program will include the following panel discussions:

  • health data that changed the world
  • bignano
  • emerging disruptive technologies in life sciences
  • cell therapy
  • the patient: the partner since day one in life sciences
  • a new era: transforming a neurological research and care to change lives
  • healthcare financing programs
  • the Canada Eurasia biotech and healthcare digital partnering
  • certification of pharmaceutical products in Canada
  • etc.

Invited organizations and companies from Eurasia:

  • The Eurasian Economic Commission
  • Ministries and institutions of Armenia, Belarus, Kazakhstan, Kyrgyzstan, Russia, Ukraine, and Uzbekistan in charge of the development of the biotechnological industry
  • Eurasia-based regional centres of excellence
  • Industry leaders operating in the region

We will specifically cover the countries’ quality of regulation, intellectual property and the ability to protect it; the education of and availability of an expert workforce; infrastructure and the country's R&D.


Virtual matchmaking with Canadian and Eurasian participants will be accessible from the 15th  -17th  of March.

What’s in it for you?

  • Establish contacts with Canadian, Eurasian and American entities in the biotech and healthcare industries
  • Get prepared to export or import
  • Attract financing
  • Find partners in Canada or Eurasia
  • Invest in Canada or Eurasia
  • Get a job in the field of biotech and healthcare


THE PROJECT IS SUPPORTED BY

     
     

For  more information, please, contact

 Marina Belskikh, Regional Director of CERBA in Montreal and Ottawa, 

via email [email protected] or tel. +1  (514) 5161178

and

Alex Grichine, Regional Director of CERBA in Moscow

via emai[email protected] or tel. +7 (495) 134-0268.